Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-19

Clinical Trial Update: Efficacy and Safety of Dignicap System for Preventing Chemotherapy Induced Alopecia [NA]

View source ↗

Summary

Update on a clinical trial evaluating the efficacy and safety of the DigniCap scalp cooling system to prevent chemotherapy-induced hair loss in breast cancer pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DigniCap Scalp Cooling System (scalp cooling device)

Snippet

Sponsor: Target Health Inc. | Conditions: Chemotherapy Adjuvant, Breast Cancer | NA | Status: UNKNOWN